期刊文献+

丙戊酸钠缓释片致血小板减少及上消化道出血 被引量:11

Thrombocytopenia and upper gastrointestinal haemorrhage induced by sustained-release sodium valproate tablets
原文传递
导出
摘要 1例91岁男性大疱类天疱疮患者长期口服醋酸泼尼松片5 mg/d。因癫痫发作给予丙戊酸钠缓释片250 mg,1次/d口服。5个月后剂量加至500 mg,1次/d口服。2周后患者排成形柏油便3次。实验室检查示Hb 84 g/L,PLT 45×109/L;粪潜血(+)。丙戊酸钠缓释片遂减量至125 mg,1次/d,并行对症治疗。7 d后血小板恢复正常,上消化道出血停止。 A 91-year-old man with bullous pemphigoid took long-term oral prednisone acetate tablets 5 mg/d.He received sustained-release sodium valproate 250 mg once daily for epileptic seizure.Five months later,the dosage was increased to 500 mg once daily.After 2 weeks,the patient experienced 3 tarry stools.Laboratory tests revealed the following levels: Hb 84 g/L,PLT 45×109/L;stool occult blood(+).Sustained-release sodium valproate tablets was decreased to 125 mg once daily and symptomatic therapy was given.Seven days later,his platelet count normalized and upper gastrointestinal haemorrhage subsided.
出处 《药物不良反应杂志》 2009年第6期434-435,共2页 Adverse Drug Reactions Journal
关键词 丙戊酸钠缓释片 不良反应 血小板减少 上消化道出血 sustained-release sodium valproate tablets adverse reactions thrombocytopenia upper gastrointestinal haemorrhage
  • 相关文献

参考文献4

二级参考文献12

  • 1Perucca E. Pharmacological and therapeutic properties of valproate:a summary after 35 years of clinical experience. CNS Drugs,2002,16(10): 695.
  • 2Wangemann M, Retzow A, Vens CB. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate. Int J Clin Pharmacol Ther, 1999,37(2): 100.
  • 3Loscher W, Honack D. Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous ("controlled release") administration in a model of generalized seizures in rats. Epilepsia, 1995,36(9) :929.
  • 4Robert S,Greenwood.Adverse effects of anti-epileptic drugs[].Epilepsia.2000
  • 5Schlienger RG,Shear NH.Anti-epileptic drug hypersensitivity syndrome[].Epilepsia.1998
  • 6Park BK,Pirmohamed K,Kiitteringham NR,et al.Idiosyncratic drug reactions: a mechanistic evaluation of risk factor[].British Journal of Clinical Pharmacology.1992
  • 7Kreuz W,Linde R,Frunk M,et al.Valproate therapy induces von Willebrand disease type[].Epilepsia.1992
  • 8David RG,Sunder T,Barakat HA,et al.Valproate alters the membrane phospholipids of erythrocytes[].Epilepsia.1991
  • 9Pirmohamed M,Kitteringham NR,Park BK,et al.The role of active metabolites in drug toxicity[].Drug Safety.1994
  • 10Ronald B,May TR,Sunder.Hematologic manifestation of longterm valproate therapy[].Epilepsia.1993

共引文献10

同被引文献65

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部